anonymous
Guest
anonymous
Guest
Some interesting stats and mentions of the GYN business on the call. And SM making a strong statement about pursuing Minerva to stop selling the device in the US.
Some interesting stats and mentions of the GYN business on the call. And SM making a strong statement about pursuing Minerva to stop selling the device in the US.
Minerva has 15 percent share.Lol someone tell the Mathematicion from Minerva that the Novasure YOY decline is not a clean indicator of Minerva market share.
Minerva is in the high single-digits if we’re being generous. We are fighting for share in a declining category.
The decline in sales is really due to the GYN leadership team continuously embarrassing themselves with every personnel and tactical decision they make. It’s hilarious over here.
So if you guys can’t beat us now, believe me when I tell you that you never will.
Lol someone tell the Mathematicion from Minerva that the Novasure YOY decline is not a clean indicator of Minerva market share.
Minerva is in the high single-digits if we’re being generous. We are fighting for share in a declining category.
The decline in sales is really due to the GYN leadership team continuously embarrassing themselves with every personnel and tactical decision they make. It’s hilarious over here.
So if you guys can’t beat us now, believe me when I tell you that you never will.
You have a better chance of meeting Santa and the Easter Bunny before you ever get Minerva pulled from the market....